Treat to target in Crohn's disease: a practical guide for clinicians

AR Srinivasan - World Journal of Gastroenterology, 2024 - pmc.ncbi.nlm.nih.gov
A treat-to-target (T2T) approach applies the principles of early intervention and tight disease
control to optimise long-term outcomes in Crohn's disease. The Selecting Therapeutic …

Overlap** irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?

EMM Quigley - Therapeutic advances in gastroenterology, 2016 - journals.sagepub.com
Though distinct in terms of pathology, natural history and therapeutic approach, irritable
bowel syndrome (IBS) and inflammatory bowel disease (IBD) have some features in …

Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology

RP Arasaradnam, S Brown, A Forbes, MR Fox… - Gut, 2018 - gut.bmj.com
Chronic diarrhoea is a common problem, hence clear guidance on investigations is
required. This is an updated guideline from 2003 for the investigations of chronic diarrhoea …

Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson's disease

L Dumitrescu, D Marta, A Dănău, A Lefter… - Frontiers in …, 2021 - frontiersin.org
Parkinson's disease (PD) is characterized by alpha-synuclein misfolding with subsequent
intraneuronal amyloid formation and accumulation, low grade neuroinflammatory changes …

The use of fecal calprotectin testing in paediatric disorders: a position paper of the European Society for Paediatric Gastroenterology and Nutrition Gastroenterology …

CR Koninckx, E Donat, MA Benninga… - Journal of pediatric …, 2021 - journals.lww.com
Objectives: The aim of the study was to review the evidence regarding the clinical use and
value of fecal calprotectin (FC) measurements in different gastrointestinal disorders in …

Fermentable carbohydrates [FODMAPs] exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind …

SR Cox, AC Prince, CE Myers, PM Irving… - Journal of Crohn's …, 2017 - academic.oup.com
Abstract Background and Aims Preliminary evidence suggests that fermentable
carbohydrate restriction might ameliorate functional gastrointestinal symptoms [FGS] in …

Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients

MM Widlak, CL Thomas, MG Thomas… - Alimentary …, 2017 - Wiley Online Library
Background The diagnosis of colorectal cancer (CRC) can be difficult as symptoms are
variable with poor specificity. Thus, there is a quest for simple, non‐invasive testing that can …

[HTML][HTML] Association between level of fecal calprotectin and progression of Crohn's disease

NA Kennedy, GR Jones, N Plevris, R Patenden… - Clinical …, 2019 - Elsevier
Background & Aims Mucosal healing is associated with improved outcomes in patients with
Crohn's disease (CD), but assessment typically requires ileocolonoscopy. Calprotectin can …

A double‐blind, placebo‐controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea‐predominant IBS

K Hod, AD Sperber, Y Ron, M Boaz… - …, 2017 - Wiley Online Library
Background Micro‐inflammation is considered an element in the pathogenesis of irritable
bowel syndrome (IBS). High‐sensitivity C reactive protein (hs‐CRP) was previously shown …

Biomarkers in inflammatory bowel disease: a practical guide

J Clough, M Colwill, A Poullis, R Pollok… - Therapeutic …, 2024 - journals.sagepub.com
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …